Skip to main content

Table 3 Patient characteristics

From: An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138+ cells

      Plasma cell myeloma type

Disease stage

Percentage of plasma cell bone marrow infiltratin

Kappa/lambda ratio

IgA

lambda

IIIA

66.1%

0.0107

IgA

lambda

IIIB

28.4%

0.0514

IgA

lambda

IIIA

63.3%

0.1045

IgA

lambda

IIIA

43.5%

0.1747

IgA

kappa

IIA

88.2%

1.526

IgG

lambda

IIB

78.1%

0.00102

IgG

lambda

IIIB

30.3%

0.00703

IgG

lambda

IIIA

59.8%

0.00834

IgG

lambda

IIIA

20.7%

0.00127

IgG

lambda

IIB

66.1%

0.0161

IgG

lambda

IIB

59.9%

0.0115

IgG

lambda

IIIB

32.2%

0.0232

IgG

lambda

IIIA

40.1%

0.0418

IgG

lambda

IIIA

20.2%

0.0430

IgG

lambda

IIIB

20.6%

0.0509

IgG

lambda

IIIA

12.3%

0.0604

IgG

kappa

IIIA

13.4%

1.009

IgG

kappa

IA

37.2%

1.522

IgG

kappa

IA

35.0%

15.16

IgG

kappa

IIIb

20.4%

24.02

IgG

kappa

IIIA

9.8%

478.5

IgM

kappa

IIIA

59.5%

16.74

IgM

kappa

IIIA

10.5%

165.1

Bence-Jones

lambda

IIA

6.1%

0.0944

Bence-Jones

lambda

IIIA

67.0%

0.361

Bence-Jones

kappa

IIA

76.8%

52.66

Non-secretary

lambda

IIIB

41.6%

0.0672